Skip to main content

8 Result(s)

within G. Fanetti Remove this filter

and

  1. No Access

    Article

    Predictive Value of CD8 Expression and FoxP3 Methylation in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy in a Non-endemic Area

    Undifferentiated Nasopharyngeal Carcinoma (UNPC) is associated with Epstein-Barr Virus (EBV) and characterized by an abundant immune infiltrate potentially influencing the prognosis. Thus, we retrospectively a...

    E. Muraro, E. Vaccher, C. Furlan, E. Fratta, G. Fanetti… in Pathology & Oncology Research (2020)

  2. No Access

    Article

    Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer

    To report toxicity and efficacy outcome of moderately hypofractionated image-guided external-beam radiotherapy in a large series of patients treated for prostate cancer (PCa). Between 10/2006 and 12/2015, 572 ...

    B. A. Jereczek-Fossa, A. Maucieri, G. Marvaso, S. Gandini, C. Fodor… in Medical Oncology (2018)

  3. No Access

    Article

    Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology

    Many concerns are related to the idea that the acute toxicity of induction chemotherapy (IC) performed with TPF (docetaxel, cisplatin, 5-fluorouracil) could reduce the ability to deliver the subsequent standar...

    D. Alterio, M. Cossu Rocca, W. Russell-Edu, S. Dicuonzo, G. Fanetti… in Medical Oncology (2017)

  4. No Access

    Article

    Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients

    Currently, first-line chemotherapy in advanced colorectal cancer is not tailored on predictive biomarkers. Bax proapoptotic protein may correlate to chemosensitivity and differential response to irinotecan or ...

    F. Pietrantonio, P. Biondani, M. Milione, F. Melotti… in Clinical and Translational Oncology (2013)

  5. No Access

    Article

    Multiple sclerosis onset after antitetanus toxoid immunoglobulin prophylaxis

    P. Annunziata, C. Traversi, G. Fanetti… in The Italian Journal of Neurological Scienc… (1993)

  6. No Access

    Chapter and Conference Paper

    Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus

    Synthetic octapeptides spanning the 119–147 region of the Hepatitis C Virus (HCV) CI00 protein were tested on HCV positive sera. The 138–145 region proved to be antigenic and possibly able to avoid undesired c...

    Dr. P. Neri, A. Bonci, G. Campoccia, G. Fanetti… in Chronically Evolving Viral Hepatitis (1992)

  7. No Access

    Article

    Impact of hepatitis a in Siena: A “traveller's disease”?

    Over a period of seven years (from 1980 to 1987) 58 acute viral hepatitis A cases were admitted to the Departments for Infectious Diseases. This number represents 10.76% of all viral hepatitis patients. Most o...

    A. Braito, C. Cellesi, O. Fanti, F. Civitelli… in European Journal of Epidemiology (1990)

  8. No Access

    Article

    Anti-HTLV-I antibodies in the serum and CSF from amyotrophic lateral sclerosis patients: negative findings

    P. Annunziata, M. Giarratana, A. M. Aucone, A. D'Andrea, G. Fanetti… in Journal of Neurology (1989)